{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:29:06Z","timestamp":1789648146429,"version":"4.0.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-05104-w","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:57:22Z","timestamp":1761562642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Maximum tolerated medication dose and other predictors of mortality in heart failure with reduced ejection fraction: retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Joule J.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daya Ram","family":"Parajuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Eng-Frost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepehr","family":"Shakib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"issue":"15","key":"5104_CR1","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1093\/eurjpc\/zwaa147","volume":"28","author":"NL Bragazzi","year":"2021","unstructured":"Bragazzi NL, Zhong W, Shu J, Abu Much A, Lotan D, Grupper A, et al. Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017. Eur J Prev Cardiol. 2021;28(15):1682\u201390.","journal-title":"Eur J Prev Cardiol"},{"issue":"17","key":"5104_CR2","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1136\/heartjnl-2021-320131","volume":"108","author":"S Emmons-Bell","year":"2022","unstructured":"Emmons-Bell S, Johnson C, Roth G. Prevalence, incidence and survival of heart failure: a systematic review. Heart. 2022;108(17):1351\u201360.","journal-title":"Heart"},{"issue":"18","key":"5104_CR3","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines. Circulation. 2022;145(18):e895-1032.","journal-title":"Circulation"},{"key":"5104_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ahj.2022.05.018","volume":"251","author":"JB Pierce","year":"2022","unstructured":"Pierce JB, Mentz RJ, Sun JL, Alhanti B, Whellan DJ, Kraus WE, et al. Titration of medical therapy and clinical outcomes among patients with heart failure with reduced ejection fraction: findings from the HF-ACTION trial. Am Heart J. 2022;251:115\u201326.","journal-title":"Am Heart J"},{"issue":"2","key":"5104_CR5","doi-asserted-by":"publisher","first-page":"e0212907","DOI":"10.1371\/journal.pone.0212907","volume":"14","author":"RD Turgeon","year":"2019","unstructured":"Turgeon RD, Kolber MR, Loewen P, Ellis U, McCormack JP. Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: systematic review and meta-analysis. PLoS ONE. 2019;14(2):e0212907.","journal-title":"PLoS ONE"},{"issue":"15","key":"5104_CR6","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1001\/archinte.162.15.1682","volume":"162","author":"A Heiat","year":"2002","unstructured":"Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med. 2002;162(15):1682\u20138.","journal-title":"Arch Intern Med"},{"key":"5104_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ijcard.2017.01.153","volume":"236","author":"QE Denfeld","year":"2017","unstructured":"Denfeld QE, Winters-Stone K, Mudd JO, Gelow JM, Kurdi S, Lee CS. The prevalence of frailty in heart failure: A systematic review and meta-analysis. Int J Cardiol. 2017;236:283\u20139.","journal-title":"Int J Cardiol"},{"issue":"1","key":"5104_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12872-021-01868-z","volume":"21","author":"DR Parajuli","year":"2021","unstructured":"Parajuli DR, Shakib S, Eng-Frost J, McKinnon RA, Caughey GE, Whitehead D. Evaluation of the prescribing practice of guideline-directed medical therapy among ambulatory chronic heart failure patients. BMC Cardiovasc Disord. 2021;21(1):104.","journal-title":"BMC Cardiovasc Disord"},{"issue":"27","key":"5104_CR9","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC)Developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129\u2013200.","journal-title":"Eur Heart J"},{"issue":"3","key":"5104_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S van Buuren","year":"2011","unstructured":"van Buuren S, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45(3):1\u201367.","journal-title":"J Stat Softw"},{"key":"5104_CR11","doi-asserted-by":"crossref","unstructured":"Hosmer DW Jr, Lemeshow S, May S. Applied survival analysis: regression modeling of time-to-event data. New York. Wiley; 2008 .","DOI":"10.1002\/9780470258019"},{"key":"5104_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1471-2288-9-57","volume":"9","author":"A Marshall","year":"2009","unstructured":"Marshall A, Altman DG, Holder RL, Royston P. Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines. BMC Med Res Methodol. 2009;9:57.","journal-title":"BMC Med Res Methodol"},{"issue":"36","key":"5104_CR13","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599\u2013726.","journal-title":"Eur Heart J"},{"key":"5104_CR14","doi-asserted-by":"publisher","first-page":"i1855","DOI":"10.1136\/bmj.i1855","volume":"353","author":"D Kotecha","year":"2016","unstructured":"Kotecha D, Manzano L, Krum H, Rosano G, Holmes J, Altman DG, et al. Effect of age and sex on efficacy and tolerability of \u03b2 blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis. BMJ. 2016;353:i1855.","journal-title":"BMJ"},{"issue":"9","key":"5104_CR15","doi-asserted-by":"publisher","first-page":"e059905","DOI":"10.1136\/bmjopen-2021-059905","volume":"12","author":"Y Sharma","year":"2022","unstructured":"Sharma Y, Horwood C, Hakendorf P, Thompson C. Benefits of heart failure-specific pharmacotherapy in frail hospitalised patients: a cross-sectional study. BMJ Open. 2022;12(9):e059905.","journal-title":"BMJ Open"},{"issue":"3","key":"5104_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","volume":"26","author":"MD Flather","year":"2005","unstructured":"Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J. 2005;26(3):215\u201325.","journal-title":"Eur Heart J"},{"issue":"3","key":"5104_CR17","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/ejhf.1799","volume":"23","author":"IR Mordi","year":"2021","unstructured":"Mordi IR, Ouwerkerk W, Anker SD, Cleland JG, Dickstein K, Metra M, et al. Heart failure treatment up-titration and outcome and age: an analysis of BIOSTAT-CHF. Eur J Heart Fail. 2021;23(3):436\u201344.","journal-title":"Eur J Heart Fail"},{"key":"5104_CR18","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.ijcard.2015.03.428","volume":"187","author":"SB Barywani","year":"2015","unstructured":"Barywani SB, Ergatoudes C, Schaufelberger M, Petzold M, Fu ML. Does the target dose of neurohormonal Blockade matter for outcome in systolic heart failure in octogenarians? Int J Cardiol. 2015;187:666\u201372.","journal-title":"Int J Cardiol"},{"issue":"9","key":"5104_CR19","doi-asserted-by":"publisher","first-page":"e1008","DOI":"10.1016\/S2214-109X(18)30306-1","volume":"6","author":"TK Teng","year":"2018","unstructured":"Teng TK, Tromp J, Tay WT, Anand I, Ouwerkerk W, Chopra V, et al. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study. Lancet Glob Health. 2018;6(9):e1008-18.","journal-title":"Lancet Glob Health"},{"issue":"2","key":"5104_CR20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1001\/jamacardio.2023.4553","volume":"9","author":"G Cotter","year":"2024","unstructured":"Cotter G, Deniau B, Davison B, Edwards C, Adamo M, Arrigo M, et al. Optimization of Evidence-Based heart failure medications after an acute heart failure admission: A secondary analysis of the STRONG-HF randomized clinical trial. JAMA Cardiol. 2024;9(2):114\u201324.","journal-title":"JAMA Cardiol"},{"issue":"12","key":"5104_CR21","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.hlc.2020.04.012","volume":"29","author":"A Driscoll","year":"2020","unstructured":"Driscoll A, Dinh D, Wong J, Hopper I, Mariani J, Zimmet H, et al. Impact of individual patient profiles on adherence to guideline directed medical therapy in heart failure with reduced ejection fraction: VCOR-HF study. Heart Lung Circ. 2020;29(12):1782\u20139.","journal-title":"Heart Lung Circ"},{"issue":"5","key":"5104_CR22","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1002\/jcsm.13306","volume":"14","author":"KM Talha","year":"2023","unstructured":"Talha KM, Pandey A, Fudim M, Butler J, Anker SD, Khan MS. Frailty and heart failure: State-of-the-art review. J Cachexia Sarcopenia Muscle. 2023;14(5):1959\u201372. https:\/\/doi.org\/10.1002\/jcsm.13306.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"5104_CR23","doi-asserted-by":"crossref","unstructured":"Stolfo D, Iacoviello M, Chioncel O, Anker MS, Bayes-Genis A, Braunschweig F et al. How to handle polypharmacy in heart failure. A clinical consensus statement of the heart failure.Association of the ESC. Eur J Heart Fail. 2025 May;27(5):747-759.","DOI":"10.1002\/ejhf.3642"},{"issue":"1","key":"5104_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/ehf2.14137","volume":"10","author":"J Henrysson","year":"2023","unstructured":"Henrysson J, Thunstr\u00f6m E, Chen X, Fu M, Basic C. Hyperkalaemia as a cause of undertreatment with mineralocorticoid receptor antagonists in heart failure. ESC Heart Fail. 2023;10(1):66\u201379.","journal-title":"ESC Heart Fail"},{"issue":"11","key":"5104_CR25","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/j.jchf.2023.06.022","volume":"11","author":"SA Swat","year":"2023","unstructured":"Swat SA, Helmkamp LJ, Tietbohl C, Thompson JS, Fitzgerald M, McIlvennan CK, et al. Clinical inertia among outpatients with heart failure: application of treatment nonintensification taxonomy to EPIC-HF trial. JACC Heart Fail. 2023;11(11):1579\u201391.","journal-title":"JACC Heart Fail"},{"key":"5104_CR26","doi-asserted-by":"crossref","unstructured":"Philbin SE, Gleason LP, Persell SD, Walter E, Petito LC, Tibrewala A et al. Barriers and facilitators to heart failure Guideline-Directed medical therapy in an integrated health system and federally qualified health centers: A thematic qualitative analysis. J Gen Intern Med. 2025 May 5. doi: 10.1007\/s11606-025-09515-5. Epub ahead of print. PMID: 40325339.","DOI":"10.1007\/s11606-025-09515-5"},{"issue":"20","key":"5104_CR27","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1001\/jamainternmed.2013.10059","volume":"173","author":"DJ Nyweide","year":"2013","unstructured":"Nyweide DJ, Anthony DL, Bynum JP, Strawderman RL, Weeks WB, Casalino LP, et al. Continuity of care and the risk of preventable hospitalization in older adults. JAMA Intern Med. 2013;173(20):1879\u201385.","journal-title":"JAMA Intern Med"},{"issue":"12","key":"5104_CR28","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1001\/jamacardio.2024.3023","volume":"9","author":"AB Tang","year":"2024","unstructured":"Tang AB, Ziaeian B, Butler J, Yancy CW, Fonarow GC. Global impact of optimal implementation of Guideline-Directed medical therapy in heart failure. JAMA Cardiol. 2024;9(12):1154\u20138.","journal-title":"JAMA Cardiol"},{"issue":"7","key":"5104_CR29","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1136\/hrt.2004.048389","volume":"91","author":"R Holland","year":"2005","unstructured":"Holland R, Battersby J, Harvey I, Lenaghan E, Smith J, Hay L. Systematic review of multidisciplinary interventions in heart failure. Heart. 2005;91(7):899\u2013906.","journal-title":"Heart"},{"issue":"4","key":"5104_CR30","first-page":"810","volume":"44","author":"FA McAlister","year":"2004","unstructured":"McAlister FA, Stewart S, Ferrua S, McMurray JJ. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol. 2004;44(4):810\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"5104_CR31","first-page":"Cd002752","volume":"1","author":"A Takeda","year":"2019","unstructured":"Takeda A, Martin N, Taylor RS, Taylor SJ. Disease management interventions for heart failure. Cochrane Database Syst Rev. 2019;1(1):Cd002752.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"5104_CR32","doi-asserted-by":"publisher","first-page":"e24599","DOI":"10.1097\/MD.0000000000024599","volume":"100","author":"X Qiu","year":"2021","unstructured":"Qiu X, Lan C, Li J, Xiao X, Li J. The effect of nurse-led interventions on re-admission and mortality for congestive heart failure: A meta-analysis. Med (Baltim). 2021;100(7):e24599.","journal-title":"Med (Baltim)"},{"issue":"9","key":"5104_CR33","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.cardfail.2019.07.455","volume":"25","author":"DR Parajuli","year":"2019","unstructured":"Parajuli DR, Kourbelis C, Franzon J, Newman P, McKinnon RA, Shakib S, et al. Effectiveness of the Pharmacist-Involved multidisciplinary management of heart failure to improve hospitalizations and mortality rates in 4630 patients: A systematic review and Meta-Analysis of randomized controlled trials. J Card Fail. 2019;25(9):744\u201356.","journal-title":"J Card Fail"},{"key":"5104_CR34","doi-asserted-by":"crossref","unstructured":"Herrero-Torrus M, Badosa N, Roqueta C, Ruiz-Bustillo S, Sol\u00e9-Gonz\u00e1lez E, Belarte-Tornero LC et al. Randomized Controlled Trial Comparing a Multidisciplinary Intervention by a Geriatrician and a Cardiologist to Usual Care after a Heart Failure Hospitalization in Older Patients: The SENECOR Study. J Clin Med. 2022Mar 30;11(7):1932.","DOI":"10.3390\/jcm11071932"},{"issue":"10","key":"5104_CR35","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1111\/jgs.18481","volume":"71","author":"YC Lee","year":"2023","unstructured":"Lee YC, Lin JK, Ko D, Cheng S, Patorno E, Glynn RJ, et al. Frailty and uptake of angiotensin receptor Neprilysin inhibitor for heart failure with reduced ejection fraction. J Am Geriatr Soc. 2023;71(10):3110\u201321.","journal-title":"J Am Geriatr Soc"},{"key":"5104_CR36","doi-asserted-by":"crossref","unstructured":"Essa H, Walker L, Mohee K, Oguguo C, Douglas H, Kahn M et al. Multispecialty multidisciplinary input into comorbidities along with treatment optimisation in heart failure reduces hospitalisation and clinic attendance. Open Heart. 2022Jul;9(2):e001979.;","DOI":"10.1136\/openhrt-2022-001979"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05104-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05104-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05104-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:57:29Z","timestamp":1761562649000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-05104-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5104"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05104-w","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"was obtained from the Royal Adelaide Hospital Human Ethics Research Committee (R20161105). The need for informed consent to participate was waived by the Royal Adelaide Hospital Human Ethics Research Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"declaration: Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"768"}}